Study wrapper · #19
Rapid and harmonized analytical workflow for the determination of peptidic and non-peptidic doping agents in dried and liquid blood matrices.
Editor's note
This study is not a clinical or pharmacological investigation — it is a doping-control analytical methods paper, and should be read as such. Researchers developed and validated a streamlined workflow capable of detecting 54 prohibited substances, including BPC-157 and TB-500, across dried blood spots, serum, and plasma using a single microextraction step followed by liquid chromatography coupled with high-resolution mass spectrometry.
The analytical performance was satisfactory by laboratory standards: detection limits ranged from 0.05–1.25 ng/mL, no carry-over was observed, and matrix effects were modest (5–33%). Notably, dried blood spot matrices preserved all compounds for the full study duration under non-refrigerated conditions — a meaningful practical advantage for anti-doping sample logistics.
For readers tracking BPC-157 and TB-500 specifically: the stability data are striking. Both peptides showed complete degradation in serum within one week at room temperature or refrigerator temperature — a finding with direct implications for detection windows in anti-doping contexts. Dried matrices retained detectability throughout.
This paper contributes nothing to the...
Plain-language abstract
Researchers at an analytical laboratory developed and tested a faster, simpler method for detecting 54 substances banned in sports — including several peptides — across three types of blood samples: dried blood spots (small samples dried on a card), serum, and plasma.
Instead of the multiple preparation steps typically required, the new workflow uses a single extraction step with a methanol-water mixture, followed by a highly sensitive detection technique that separates and identifies compounds by their mass. The method was validated against standard laboratory criteria and performed well: it detected target substances at very low concentrations (0.05–1.25 nanograms per millilitre), showed no contamination between samples, and produced stable results.
The study also examined how long the banned compounds remained detectable under different storage conditions. In dried blood spot samples, all 54 compounds remained detectable throughout the entire study period — even when stored without refrigeration — suggesting this format is better suited for transporting samples from remote locations. In liquid serum and plasma kept at room temperature or standard refrigerator temperature, several peptides including BPC-157, TB-500, vasopressin, lypressin, and terlipressin degraded completely within one week. Other peptides including alexamorelin, AOD9604, buserelin, and kisspeptin-10 degraded extensively in both serum and plasma under the same conditions.
The method was successfully...